33% is significant in the scheme of where they should be now. The others may not be at the same timeline, and unfortunately, even IF they have continued to deteriorate it has been at a much slower timeframe.
Which also concludes, this is the best drug soon to be on the market to date.
Remember its a orphan drug.
33% is significant in the scheme of where they should be now....
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
-0.005(3.03%) |
Mkt cap ! $77.79M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 17.5¢ | 15.5¢ | $280.7K | 1.733M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 195397 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 43952 | 1 |
View Market Depth
| Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |